Tumor-targeting oncolytic viruses engineered for glioblastoma immunotherapy
RNA-seq (gene expression) · mouse · 48 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 48 samples: 48 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE244034_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1021139 and SRA study SRP463310. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 48 sample titles: 48 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7805200 CD4 T Cells Treated By Control [TAAGGCGA_TAAGGCTC]
- GSM7805201 CD4 T Cells Treated By Virus [CGTACTAG_TAAGGCTC]
- GSM7805202 CD4 T Cells Treated By Control [AGGCAGAA_TAAGGCTC]
- GSM7805203 CD4 T Cells Treated By Virus [TCCTGAGC_TAAGGCTC]
- GSM7805204 CD4 T Cells Treated By Control [GGACTCCT_TAAGGCTC]
- GSM7805205 CD4 T Cells Treated By Virus [TAGGCATG_TAAGGCTC]
- GSM7805206 CD8 T Cells Treated By Control [CTCTCTAC_TAAGGCTC]
- GSM7805207 CD8 T Cells Treated By Virus [CGAGGCTG_TAAGGCTC]
- GSM7805208 CD8 T Cells Treated By Control [AAGAGGCA_TAAGGCTC]
- GSM7805209 CD8 T Cells Treated By Virus [GTAGAGGA_TAAGGCTC]
- GSM7805210 CD8 T Cells Treated By Control [GCTCATGA_TAAGGCTC]
- GSM7805211 CD8 T Cells Treated By Virus [ATCTCAGG_TAAGGCTC]
- GSM7805212 Microglia Treated By Control [TAAGGCGA_TCGCATAA]
- GSM7805213 Microglia Treated By Virus [CGTACTAG_TCGCATAA]
- GSM7805214 Microglia Treated By Control [AGGCAGAA_TCGCATAA]
- GSM7805215 Microglia Treated By Virus [TCCTGAGC_TCGCATAA]
- GSM7805216 Microglia Treated By Control [GGACTCCT_TCGCATAA]
- GSM7805217 Microglia Treated By Virus [TAGGCATG_TCGCATAA]
- GSM7805218 Monocytes Treated By Control [CTCTCTAC_TCGCATAA]
- GSM7805219 Monocytes Treated By Virus [CGAGGCTG_TCGCATAA]
- GSM7805220 Monocytes Treated By Control [AAGAGGCA_TCGCATAA]
- GSM7805221 Monocytes Treated By Virus [GTAGAGGA_TCGCATAA]
- GSM7805222 Monocytes Treated By Control [GCTCATGA_TCGCATAA]
- GSM7805223 Monocytes Treated By Virus [ATCTCAGG_TCGCATAA]
- GSM7805224 Macrophage treated by Virus Empty [5ADB.TAGCGCTC_AGAGGATA]
- GSM7805225 Macrophage treated by Virus Empty [5ADB.ACTGAGCG_AGAGGATA]
- GSM7805226 Macrophage treated by Virus Empty [5ADB.CCTAAGAC_AGAGGATA]
- GSM7805227 CD4 T Cells treated by Virus Empty [5ADB.CGATCAGT_AGAGGATA]
- GSM7805228 CD4 T Cells treated by Virus Empty [5ADB.TGCAGCTA_AGAGGATA]
- GSM7805229 CD4 T Cells treated by Virus Empty [5ADB.TCGACGTC_AGAGGATA]
- GSM7805230 CD8 T Cells treated by Virus Empty [5ADB.ACTCGCTA_CTCCTTAC]
- GSM7805231 CD8 T Cells treated by Virus Empty [5ADB.GGAGCTAC_CTCCTTAC]
- GSM7805232 CD8 T Cells treated by Virus Empty [5ADB.GCGTAGTA_CTCCTTAC]
- GSM7805233 NK Cells treated by Virus Empty [5ADB.CGGAGCCT_CTCCTTAC]
- GSM7805234 NK Cells treated by Virus Empty [5ADB.TACGCTGC_CTCCTTAC]
- GSM7805235 NK Cells treated by Virus Empty [5ADB.ATGCGCAG_CTCCTTAC]
- GSM7805236 Macrophage treated by Virus 2206 [5ADB.TAGCGCTC_CTCCTTAC]
- GSM7805237 Macrophage treated by Virus 2206 [5ADB.ACTGAGCG_CTCCTTAC]
- GSM7805238 Macrophage treated by Virus 2206 [5ADB.CCTAAGAC_CTCCTTAC]
- GSM7805239 CD4 T Cells treated by Virus 2206 [5ADB.CGATCAGT_CTCCTTAC]
+ 8 more — browse all 48 samples with per-sample file links →
- GSE212259 Whole-course Taming of Tumor-associated Macrophages from Central to Peripheral using Engineered Outer Membrane Vesicle Nanohybrids for Improved Immunotherapy [part 1: RNA-seq] 36 samples shares immunotherapy, engineered
- GSE238087 Nanodrug modified with engineered cancer cell membrane targets CDKs to activate PD-L1 antibody immunotherapy against liver metastasis of immune-desert colon cancer 12 samples shares immunotherapy, engineered
- GSE272424 Rejuvenating endogenous antitumor immunity via a chimeric receptor-engineered oncolytic virus targeting tumor-associated macrophages 6 samples shares engineered, oncolytic
- GSE330003 A High-Throughput Screen on Primary Glioblastoma-Associated Macrophages Identifies HDAC Inhibitors as Enhancers of Phagocytosis and Potent Partners for Immunotherapy [CUT&Tag] 14 samples shares immunotherapy, glioblastoma
- GSE249630 Modeling T cell temporal response to cancer immunotherapy rationalize development of combinatorial treatments protocols 1372 samples shares immunotherapy
- GSE215960 Subclonal evolution revealed by single-cell profiles of expressed mutations identifies adaptation mechanisms to immunotherapy in melanoma [scRNA-seq] 192 samples shares immunotherapy
- GSE216388 Engineered T cell therapy for central nervous system injury [FACS-Tcells] 192 samples shares engineered
- GSE302715 A tumor-associated macrophage-targeted immunocytokine leveraging T and NK cell synergy for potent cancer immunotherapy [scRNA-seq] 187 samples shares immunotherapy
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.